Skip to main content
Etz

Elisabeth-TweeSteden Hospital (ETZ) in Tilburg, the Netherlands, has moved from clinical study participation to full commercial adoption: cataract patients can now choose the Lumina IOL as a standard premium option. The lens was evaluated previously in the PMS study, and the positive outcomes prompted its structural integration into the clinic's offering.

"The Lumina is an excellent alternative to monofocal and EDOF lenses, with demonstrably better near vision." - Dr. Oege Goslings, ETZ Tilburg

share this article

Other updates

Img3
June 2026

Lumina resolves neuro-adaptation failure

Medipolis logo
May 2026

Eye centre Medipolis Antwerp begins commercial implantations

Technopia
April 2026

Technopia Co. Ltd. appointed exclusive distributor for Japan

Funding round
March 2026

AkkoLens closes EUR 6.3 million funding round

Arfamex
February 2026

Arfamex appointed exclusive distributor for Mexico

Mdr
September 2026

Lumina to be recertified under MDR as an accommodating IOL

Get in
contact

Whether you have a question about the Lumina lens, our company or about the availability of the Lumina, our team will be happy to provide the information you need.

Contact us

Eye care professional?

Looking for clinical information, product details or partnership opportunities? Explore our dedicated resources for healthcare professionals and industry partners.

For professionals